Implantable Cardioverter‐Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications

Implantable Cardioverter‐Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications

BackgroundArrhythmogenic right ventricular dysplasia/cardiomyopathy is characterized by ventricular arrhythmias and sudden cardiac death. Once the diagnosis is established, risk stratification to determine whether implantable cardioverter‐defibrillator (ICD) placement is warranted is critical. Metho...

Full description

Bibliographic Details
Main Authors: Gabriela M. Orgeron, Cynthia A. James, Anneline Te Riele, Crystal Tichnell, Brittney Murray, Aditya Bhonsale, Ihab R. Kamel, Stephan L. Zimmerman, Daniel P. Judge, Jane Crosson, Harikrishna Tandri, Hugh Calkins
Format: Article
Language:English
Published: Wiley 2017-11-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
arrhythmogenic right ventricular cardiomyopathy/dysplasia
implantable cardioverter defibrillator
sudden cardiac death
tachyarrhythmias
ventricular fibrillation
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.117.006242

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.117.006242

Similar Items